InvestorsHub Logo
Followers 141
Posts 24013
Boards Moderated 0
Alias Born 04/08/2004

Re: Pipilongstocking post# 334616

Wednesday, 11/03/2021 1:04:02 PM

Wednesday, November 03, 2021 1:04:02 PM

Post# of 474132
Pipilongstocking,

I am sorry to hear about your dad.

I worked with a man who was an avid bicycle rider. He averaged at least 25 miles a day. He passed away about 2 to 4 years after his first symptoms of ALS.

I do believe that Blarcamesine and/or Anavex 3-71 will work especially well for treatment of ALS and pediatric ALS.

Genetic analysis of SIGMAR1 as a cause of familial ALS with dementia

https://pubmed.ncbi.nlm.nih.gov/22739338/

Wildtype s1 receptor and the receptor agonist improve ALS-associated mutation-induced insolubility and toxicity

https://pubmed.ncbi.nlm.nih.gov/33453999/

The Sigma-1 Receptor-A Therapeutic Target for the Treatment of ALS?

https://pubmed.ncbi.nlm.nih.gov/28315276/

There are many many similar papers with supporting research.

Good luck and GOD bless,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News